Результаты поиска

Лейкемия в период беременности: диагностика и терапевтический подход (обзор).

Цель настоящего исследования заключается в оценке эпидемиологических, диагностических и терапевтических данных о гематологических заболеваниях в период беременности. Лейкемия в период беременности встречается редко, а литературные данные не являются обширными. Факторы риска, эпидемиология и патогенез этих заболеваний не разработаны в полной мере. Кроме того, имеется подробный доклад о осложнениях в период беременности и об общем (на три месяца) лечении этих заболеваний, в частности о стратегии их лечения. В настоящем исследовании описывается возможность обеспечения в будущем беременности у жен

Совпадение в полном тексте источника
… Professional advice and follow-up from specialized oncologists-hematologists and gynecologists are recommended for the potential maternal effects from the termination of therapy and the potential dangers for the fetus due to therapy. … The timing of childbirth is a shared decision of gynecologists, hematologists, oncologists and patients. Whenever it is possible and permitted by the health of the mother and the fetus, the pregnancy is allowed to be completed. …

Treatment progress of spinal metastatic cancer: a powerful tool for improving the quality of life of the patients.

Spinal metastasis is a common secondary malignant tumor of the bone, often resulting in spinal cord and nerve root compression, leading to obvious pain and related compression symptoms. This condition has a high incidence and mortality rate. The treatment approach for most patients with spinal metastasis is primarily palliative. Consultation with a multidisciplinary team is widely accepted as a comprehensive treatment approach for patients with spinal metastases. With advancements in research and technology, the evaluation and treatment of spinal metastatic cancer are continuously evolving. Th

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma.

Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal liver cancer with no proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found to synergize with a variety of systemic therapies in vitro using cells dissociated from patient-derived xenografts (PDX) of FLC or cells dissociated directly from surgical patient resections. As BCL-XL is physiologically expressed in platelets, prior efforts to leverage this vulnerability in other cancers have been hampered by severe thrombocytopenia. To overcome this toxicity, we treated FLC models with DT2216,

Совпадение в полном тексте источника
… FLC is a cancer that is cared for by both pediatric and medical oncologists. … Oncologist. 2020;25(12):e1837–e1845. doi: 10.1634/theoncologist.2020-0093. 13. El Dika I, et al. …

Fracture Risk Evaluation of Bone Metastases: A Burning Issue.

Major progress has been achieved to treat cancer patients and survival has improved considerably, even for stage-IV bone metastatic patients. Locomotive health has become a crucial issue for patient autonomy and quality of life. The centerpiece of the reflection lies in the fracture risk evaluation of bone metastasis to guide physician decision regarding physical activity, antiresorptive agent prescription, and local intervention by radiotherapy, surgery, and interventional radiology. A key mandatory step, since bone metastases may be asymptomatic and disseminated throughout the skeleton, is t

Совпадение в полном тексте источника
… Thus, oncologists ought to develop transversal multidisciplinary health care teams involving onco-rheumatologists, cancer trained orthopedic surgeons, locomotor radiologists, radiation therapists, and the referral oncologist. … Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: An assessment of instability secondary to spinal metastases. Radiat. Oncol. 2014;9:69. doi: 10.1186/1748-717X-9-69. 64. …

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.

The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein, we highlight the challenges in caring for patients with acute leukaemias and myeloid neoplasms amid the COVID-19 pandemic. We summarise key changes related to service allocation, clinical and supportive care, clinical trial participation, and ethical considerations regarding the use of lifesaving measures for these patients. We recognise that these

Совпадение в полном тексте источника
… The experts on our panel are haematologists and oncologists who are highly specialised in leukaemia, myeloid neoplasms, and transplant care. Discussions were held through virtual, online meetings. … Acknowledgments Acknowledgments The experts on this panel are haematologists and oncologists who specialise in leukaemia and transplant care, and discussions were held through virtual, online meetings. No external support was received for this Viewpoint. …

NETs: organ-related epigenetic derangements and potential clinical applications.

High-throughput next-generation sequencing methods have recently provided a detailed picture of the genetic landscape of neuroendocrine tumors (NETs), revealing recurrent mutations of chromatin-remodeling genes and little-to-no pathogenetic role for oncogenes commonly mutated in cancer. Concurrently, multiple epigenetic modifications have been described across the whole spectrum of NETs, and their putative function as tumorigenic drivers has been envisaged. As result, it is still unclear whether or not NETs are epigenetically-driven, rather than genetically-induced malignancies. Although the N

Nirogacestat and its potential impact on desmoid tumor.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Clinical development of targeted and immune based anti-cancer therapies.

Cancer is currently the second leading cause of death globally and is expected to be responsible for approximately 9.6 million deaths in 2018. With an unprecedented understanding of the molecular pathways that drive the development and progression of human cancers, novel targeted therapies have become an exciting new development for anti-cancer medicine. These targeted therapies, also known as biologic therapies, have become a major modality of medical treatment, by acting to block the growth of cancer cells by specifically targeting molecules required for cell growth and tumorigenesis. Due to

Цитоплания и инфекция после цитакабагена автолейкеля в сильно обработанном реанимированном или рефрактном миеломе.

В феврале Управление по контролю за продуктами питания и лекарственными препаратами одобрило автолекцию Ciltaakabtagene (cilta-cel). 2022 для лечения повторной/реактивной множественной миэломы после four циклы терапии. По поводу CARTITUDE-1 в ходе судебного разбирательства, ≥3 Широко распространены цитопентия и инфекции. Здесь мы пытались охарактеризовать цитопению и инфекцию после вливания цита-села в стандартную систему ухода. Это многоцентральное, ретроспективное исследование включало 105 - пациенты, получившие цилта-сел; 91 Днем 90 и 49 Днем 180 о последующей деятельности. Класс должности

Совпадение в полном тексте источника
… of some cell lineages, with an initial dip from lymphodepletion, improvement, and subsequent worsening. 27 , 28 Treatment of cytopenias included growth factor support and transfusions and the data provide expectations on supportive care and management as patients may transition back to their local oncologists … The management of cytopenias often requires close collaboration between the CAR T-cell center and local oncologists. …

Effects of Parkinson's disease on survival in cancer survivors: a retrospective, multicentre cohort study in Japan.

Aging populations and advances in medical care have contributed to an increase in the number of patients with Parkinson's disease and cancer survivors. However, the effects of Parkinson's disease on the survival of patients with cancer remain unclear. We aimed to investigate the effect of Parkinson's disease on the prognosis of patients with cancer. This retrospective multicentre cohort study used data from the Osaka Cancer Registry, which was linked to administrative data obtained between 2010 and 2015 in Japan. Patients with cancer who were followed up for 5 years after cancer diagnosis were

Совпадение в полном тексте источника
… Our study also emphasizes the importance of collaboration between oncologists and neurologists. Oncologists should be aware of the comorbidities in their patients. …

Bone scintigraphy and positron emission tomography in the early diagnosis of MRONJ.

OBJECTIVES: The aim of this study is to evaluate the bone scintigraphy (BS) and positron emission tomography (PET) in the early diagnosis of medication-related osteonecrosis of the jaws (MRONJ) and their possible use in the identification of patients at risk for MRONJ. MATERIAL AND METHODS: Thirty-one patients treated with ONJ-related drugs and who had undergone BS or PET for the evaluation of bone lesions were included in the study. The jaws of each patient were divided into four areas. For each area, the presence of pathological tracer uptake was evaluated and related to the eventual MRONJ

Радиологическое и патологическое восприятие остеонекроза, связанного с лекарственными препаратами, у < < Жо > > , больного миеломой: доклад 3 Дела.

Связанный с лекарственными препаратами остеонекроз челюсти (MRONJ) является редким побочным эффектом некоторых лекарственных средств, главным образом тех, которые используются при лечении конкретных раковых заболеваний и при первоначальном лечении ненеопластических заболеваний. Первые случаи остеонекроза челюсти были зарегистрированы в ходе 2 десятилетия назад у пациентов, употребляющих бисфофонаты (БП). После идентификации номенклатура перешла от остеонекроза челюсти (BRONJ) к MRONJ, поскольку другие лекарства могут вызвать такую же реакцию. Инвазивные стоматологические услуги, такие, как экс

Совпадение в полном тексте источника
… Due to the complexity of diagnosing and managing MRONJ, a coordinated approach from an interdisciplinary team consisting of dentists, oral and maxillofacial surgeons, radio-oncologists, pathologists, radiologists, and nuclear medicine physicians, is advised [ 27 ]. … Although no individual management strategy or collection of strategies will eliminate all MRONJ risks, it is recommended that patients should be referred to a multidisciplinary team consisting of experienced dentists for consultation as soon as the oncologists prescribe anti-resorptive therapy. …

Beyond oncology: Selinexor's journey into anti-inflammatory treatment and long-term management.

Selinexor, a selective inhibitor of nuclear export (SINE), is gaining recognition beyond oncology for its potential in anti-inflammatory therapy. This review elucidates Selinexor's dual action, highlighting its anti-tumor efficacy in various cancers including hematologic malignancies and solid tumors, and its promising anti-inflammatory effects. In cancer treatment, Selinexor has demonstrated benefits as monotherapy and in combination with other therapeutics, particularly in drug-resistant cases. Its role in enhancing the effectiveness of bone marrow transplants has also been noted. Importantl

Experiences of Multiple Myeloma Patients With Treatment in the Palestinian Practice: A Multicenter Qualitative Study in a Resource-Limited Healthcare System.

Background Multiple myeloma is a crippling cancer that puts a significant strain on patients and their families alike. The long and exhausting treatment journey with the disease is challenging not only for patients but also for healthcare systems. This exploratory study was conducted to look into these patients' experiences with their treatment and explore their recommendations and views to improve the Palestinian healthcare system, which can be viewed as an evolving healthcare system within a resource-limited and developing country. Methods The consolidated criteria for reporting qualitative

Совпадение в полном тексте источника
… Recruitment of interviewees The study participants were located, invited, and recruited with the help of hemato-oncologists who provide care for this subset of patients. The approach of purposive sampling was applied. … Four researchers and hemato-oncologists assessed the interview schedule to verify face and content validity. The final interview schedule kept the questions that the four panelists determined to be acceptable. Discussions and agreement were used to settle differences in the panelists’ perspectives. …

Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws in Bone Metastatic Breast and Prostate Cancer under Zoledronate Treatment: A Retrospective Analysis from 10 Years of Evaluation.

OBJECTIVE: This study aims to analyze the risk factors for BRONJ in patients taking zoledronic acid (ZA) for metastatic breast and prostate cancer. METHODS: For this, a retrospective, quantitative, observational cohort study was conducted using data on adverse effects in the oral cavity in patients during chemotherapy for treatment of solid tumors available in the electronic patient record system of the Haroldo Juaçaba Hospital/Ceará Cancer Institute in the period from 2010, to 2019. Data were tabulated in Excel and exported to SPSS v20.0 software for statistical analysis, with 95% confidence

MRONJ of the Mandible-From Decortication to a Complex Jaw Reconstruction Using a CAD/CAM-Guided Bilateral Scapula Flap.

Medication-related osteonecrosis of the jaw (MRONJ) has been an integral part of the maxillofacial patient population for some time. The therapeutic concept ranges from conservative approaches over less extended decortications to major jaw resections, which can result in a considerable loss of quality of life. Based on three case reports, this paper presents the long-term history of patients with MRONJ of the mandible, whose disease ultimately resulted in partial or total mandibular resection and subsequent multisegmental reconstruction using a microvascular anastomosed bone flap. Furthermore,

Совпадение в полном тексте источника
… Therefore, the full competence and interdisciplinary cooperation of oncologists, dentists, and oral and maxillofacial surgeons are a key requirement for not only early detection and sufficient treatment but also for the prevention of its development. … In the author’s opinion, the causes are the continued insufficient education of patients treated with antiresorptives due to low awareness of the treating orthopedist or oncologist, but also the dentist. …

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents.

Throughout the last decades, newly developed chemotherapeutic agents and immunotherapies that target signaling pathways have provided patients with better prognoses, improved their quality of life and increased survival rates, thus converting cancer to a stable chronic disease. However, non-anthracycline cancer chemotherapy agents and immunotherapies including human epidermal growth factor receptor 2 (HER2) inhibitors, vascular endothelial growth factor (VEGF) inhibitors, Bcr-Abl tyrosine-kinase inhibitors (TKI), proteasome inhibitors, immune checkpoint inhibitors and chimeric antigen receptor

Совпадение в полном тексте источника
… Choose the best regimen and closely monitor for cardiotoxic manifestations Close collaboration between cardiologists and oncologists for choosing the best regimen Prefer agents with minimal cardiotoxic effects, at maximal tolerated dose Monitor for early signs of cardiotoxicity (recommended every 3 months … Oncologist. 2018;23:879–886. doi: 10.1634/theoncologist.2018-0130. 30. Mahmood S.S., Fradley M.G., Cohen J.V., Nohria A., Reynolds K.L., Heinzerling L.M., Sullivan R.J., Damrongwatanasuk R., Chen C.L., Gupta D., et al. Myocarditis in Patients Treated with Immune Checkpoint Inhibitors. J. Am. Coll. …

Palbociclib regulates the expression of dihydrofolate reductase and the cell cycle to inhibit t (11;14) multiple myeloma.

BackgroundMultiple myeloma (MM) with t (11;14) has a unique biology. New combinations of novel agents are needed to improve the prognosis of patients with t (11;14) MM. As a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), palbociclib (PAL) has been used to treat various malignancies, including breast cancer, ovarian cancer, and so on. However, the effects of PAL on MM remain unclear, and thus, further investigations are warranted.MethodsTwo t (11;14) MM cell lines, U266 and KMS27, were used in this study. The cell viability and cell cycle were detected to evaluate the anti-my

Outcomes and prognostic factors after surgery for bone metastases in the extremities and pelvis: A retrospective analysis of 140 patients.

BACKGROUND: Surgical therapy of bone metastases is becoming increasingly important due to prolonged life expectancy and improved oncological treatment options. In a mostly palliative approach, it is necessary to identify those patients who might benefit from surgery. The shorter the remaining lifetime, the more restricted the indication and the less radical the intervention should be. The aim of this study was to evaluate the postoperative outcomes and prognostic factors for survival of patients with surgically treated bone metastases. METHODS: We retrospectively included 140 patients who und

Совпадение в полном тексте источника
… Although individual postoperative outcomes are known in many cases, systematic assessments of how long patients have benefited from the intervention are often missing, as follow-up treatment and examinations are frequently carried out by oncologists. … The initial choice of surgical procedure depended on the location and size of the lesion, the patient’s general condition and expected survival time, and was always discussed in a multidisciplinary setting involving radiotherapists, oncologists, pathologists and radiologists. …

Evaluation of adverse events and health-related quality of life in patients with colorectal cancer receiving ambulatory home-based chemotherapy in Thailand.

AimsTo compare adverse events and health-related quality of life in ambulatory home-based chemotherapy with those in inpatient.DesignProspective non-randomized observational study.MethodsParticipants were divided into two groups according to patients' preference receiving chemotherapy.ResultsSixty-four participants were enrolled in the inpatient, and 111 were in an ambulatory home-based chemotherapy. The frequency of anaemia, neutropenia and thrombocytopenia was significantly higher in inpatient group than in ambulatory home-based chemotherapy group (p < .001, <.001 and .002, respectively). Na

Совпадение в полном тексте источника
… In late 2015, an MDT composed of medical oncologists, nurses and pharmacists initiated the Ramathibodi home‐based chemotherapy model (RHCM) as a new healthcare service system in Thailand. … Songporn Oranratnachai, M.D., medical oncologist, Sriphat Medical Center, Faculty of Medicine, Chiangmai University for serving as a statistics consultant. We are also grateful to Dr. …